4.6 Review

Primary Neuroendocrine Tumor of the Breast: Current Understanding and Future Perspectives

Related references

Note: Only part of the references are listed.
Review Oncology

Locally Advanced Primary Small Cell Carcinoma of the Breast: A Case Report and Review of Current Evidence

Linsey Atchison et al.

Summary: Small-cell breast carcinoma is a rare and aggressive type of breast cancer with poor prognosis. Treatment typically involves chemotherapy, surgery, and radiation therapy, with triple-negative small-cell breast cancer patients requiring active surveillance.

CASE REPORTS IN ONCOLOGY (2021)

Article Endocrinology & Metabolism

Temozolomide Alone or Combined with Capecitabine for the Treatment of Metastatic Neuroendocrine Neoplasia: A Real-World Data Analysis

Alberto Bongiovanni et al.

Summary: TEM-based regimens show a high disease control rate and relatively tolerable toxicity profile in NENs of pancreatic, intestinal, and lung origin. Further investigation of these specific NETs is warranted in prospective clinical trials.

NEUROENDOCRINOLOGY (2021)

Review Oncology

Targeting mutant p53 for cancer therapy: direct and indirect strategies

Jiahao Hu et al.

Summary: TP53 is a critical tumor-suppressor gene commonly mutated in human cancers, with potential oncogenic properties when mutated. Treatments for cancers with mutant p53 involve targeting mutant p53 directly, restoring wild-type functions, and exploring synthetic lethal interactions with mutant p53 for therapeutic benefits. Additionally, disrupting noncoding RNA networks may have potential synthetic lethal effects in cancers with p53 mutations.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

Article Oncology

Validation of prognostic significance of the proposed uniform classification framework in neuroendocrine neoplasms of the breast

Libo Yang et al.

Summary: The study used the SEER database to analyze the survival outcomes of breast NENs and IDC-NST, revealing that within the same clinical stage or grade, NETs and NECs of the breast had worse disease-specific survival and overall survival compared to corresponding stage or grade IDC-NST.

BREAST CANCER RESEARCH AND TREATMENT (2021)

Editorial Material Radiology, Nuclear Medicine & Medical Imaging

177Lu-DOTATOC Peptide Receptor Radionuclide Therapy in a Patient With Neuroendocrine Breast Carcinoma and Breast Invasive Ductal Carcinoma

Qingxing Liu et al.

CLINICAL NUCLEAR MEDICINE (2020)

Review Oncology

Evolution of Neuroendocrine Tumor Therapy

Thomas M. O'Dorisio et al.

SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2020)

Article Oncology

Potential Novel Therapy Targets in Neuroendocrine Carcinomas of the Breast

Semir Vranic et al.

CLINICAL BREAST CANCER (2019)

Article Medicine, General & Internal

Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer

Fabrice Andre et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Medicine, General & Internal

Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma

Y. Loriot et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Endocrinology & Metabolism

The Evolution of Neuroendocrine Tumor Treatment Reflected by ENETS Guidelines

Wouter T. Zandee et al.

NEUROENDOCRINOLOGY (2018)

Article Endocrinology & Metabolism

Metastatic neuroendocrine neoplasia treatments in patients over 70 years of age

Alberto Bongiovanni et al.

ENDOCRINE CONNECTIONS (2018)

Article Oncology

The genetic landscape of breast carcinomas with neuroendocrine differentiation

Caterina Marchio et al.

JOURNAL OF PATHOLOGY (2017)

Letter Oncology

Neuroendocrine carcinoma of the breast: a review of 126 cases in China

Yiqun Li et al.

CHINESE JOURNAL OF CANCER (2017)

Article Medicine, General & Internal

Rare Occurrence of a Poorly Differentiated Neuroendocrine Tumor of the Bladder

Katherine Dowd et al.

CASE REPORTS IN MEDICINE (2017)

Article Anatomy & Morphology

Novel Mutations in Neuroendocrine Carcinoma of the Breast: Possible Therapeutic Targets

Daphne Ang et al.

APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2015)

Review Otorhinolaryngology

Clinical recommendations on the treatment of neuroendocrine carcinoma of the larynx: A meta-analysis of 436 reported cases

Tom P. van der Laan et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2015)

Letter Dermatology

Cutaneous spread of primary neuroendocrine breast carcinoma with apocrine differentiation

J. Santos-Juanes et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2015)

Article Oncology

Rare neuroendocrine tumours: Results of the surveillance of rare cancers in Europe project

Jan Maarten van der Zwan et al.

EUROPEAN JOURNAL OF CANCER (2013)

Article Pathology

Neuroendocrine cells associated with neuroendocrine carcinoma of the breast: nature and significance

Tomonori Kawasaki et al.

JOURNAL OF CLINICAL PATHOLOGY (2012)

Article Medicine, General & Internal

Everolimus in Postmenopausal Hormone-Receptor-Positive Advanced Breast Cancer

Jose Baselga et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Cell Biology

mTOR and cancer: many loops in one pathway

Alejo Efeyan et al.

CURRENT OPINION IN CELL BIOLOGY (2010)

Article Surgery

Neuroendocrine carcinomas of the breast

Francesca Rovera et al.

International Journal of Surgery (2008)

Article Dermatology

Multinodular cutaneous spread in neuroendocrine tumor of the breast

Kelley A. Vidulich et al.

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2007)